Gaming News

Remedy Reports Increased Revenue as New CEO Steps Up

Remedy has released its financial statement covering the 2025 fiscal year (which, unlike many other companies, actually spans January through December), and revenue is up just in time for the studio’s new CEO to take the reins.

In its latest financial results summary, Remedy says revenue has increased by 17.5% when compared to last year, although profit has fallen. It’s a similar story for the final quarter of the year; revenue is up, but profit is down.

Interim CEO Markus Mäki says that Remedy’s revenue jump in the fourth quarter can mainly be explained by Alan Wake 2 and Control sales, with the former also generating “meaningful royalties” throughout the year as a whole.

Alan Wake 2 has proven successful for Remedy throughout 2025.

Control has also done pretty well for itself; the game sold over a million copies in 2025 alone, likely driven at least in part by the announcement of sequel Control Resonant at December’s Game Awards.

Of course, it hasn’t been an entirely positive year for Remedy. In June, the studio released FBC: Firebreak, its multiplayer shooter set in Control‘s Oldest House, and in August, the studio admitted it was “unsatisfied” with the game’s sales to that point.

Indeed, in October, Mäki said Remedy was moving development resources away from FBC: Firebreak and towards other in-development titles, although he also said the studio would “respect [its] communicated roadmap” for the shooter.

Remedy’s latest financial statement comes just a day or so after the studio announced the appointment of its new CEO, Jean-Charles Gaudechon, who says he wants to both “protect what makes [Remedy] special” and “scale [the studio] in a way that builds lasting value”.

A player brandishing a melee weapon at enemies in the Remedy game FBC: Firebreak

FBC: Firebreak made 2025 a rather challenging year for Remedy.

Remedy’s board chairman Henri Österlund says Gaudechon, who has worked at companies like EA and CCP Games, is an “excellent fit” for Remedy and that the company is “well-positioned to significantly accelerate growth” under his stewardship.

We’ll have to wait and see what Gaudechon brings to Remedy in the coming months and years. Stay tuned for more on this and all other things Remedy-related.

Source link

Podcast Cover
Loading latest episode…
0 0 votes
Article Rating
Subscribe
Notify of
Favatar
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments